Determination of meglumine in pharmaceutical formulations using high performance liquid chromatography.

Four different approaches were followed for the development of a HPLC method for the determination of meglumine in solid dosage formulations: derivatization of meglumine prior to HPLC analysis, the use of an ion-pairing reagent in the mobile phase, the use of charged surface hybrid stationary phase and the use of a column designed for carbohydrate separations. The method using anionic pairing reagent in the mobile phase was shown to be suitable for the quantitative determination of meglumine in solid dosage forms. The HPLC separation was achieved on an Agilent Eclipse XDB-C18 column (150 mm x 4.

Fast racemisation of chiral amines and alcohols by using cationic half-sandwich ruthena- and iridacycle catalysts.

The lipase-catalysed resolution of alcohols and amines yields only 50 % of the desired enantiopure product. However, addition of a racemisation catalyst leads to 100 % yield in what is called a dynamic kinetic resolution (DKR). There is a need for new racemisation catalysts that are fast and compatible with the conditions of the enzymatic reaction.

Iridium/monodentate phosphoramidite catalyzed asymmetric hydrogenation of N-aryl imines.

Asymmetric hydrogenation of N-aryl acetophenone imines using iridium/PipPhos leads to very high enantioselectivities up to >99% depending on the presence of electron-donating substituents in the 2-, 3-, and 5-position of the aryl ring. If the substituent is 2-methoxy, the resultant secondary amines are easily oxidatively deprotected using trichloroisocyanuric acid to give the primary amines in good yield with full retention of enantioselectivity.